Results 121 to 130 of about 272,924 (242)

Systemic Involvement in ACS: Using CMR Imaging to Compare the Aortic Wall in Patients with and without Acute Coronary Syndrome

, 2018
Data set of patients with with and without acute coronary syndrome with CMR imaging to compare the aortic wall thickness and area. Previous studies have demonstrated that in acute coronary syndrome (ACS), plaque destabilization and vessel inflammation ...
Ivanov, MD A.
core   +1 more source

Platelet FcɣRIIa Expression Refines Clinical Risk Assessment After Myocardial Infarction

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In patients with myocardial infarction (MI), quantifying expression of platelet FcɣRIIa (pFCG) stratifies risk of subsequent MI, stroke, and death. Aims Assess the prognostic implications of clinical risk alone and in combination with the pFCG test.
David J. Schneider, Sean R. McMahon, Dominick J. Angiolillo, Alexander C. Fanaroff, Homam Ibrahim, Patrick K. Hohl, Brett L. Wanamaker, Mark B. Effron, Peter M. DiBattiste, behalf of the investigators   +9 more
wiley   +1 more source

CLINICAL ECONOMY EFFICACY OF TARGETED APPROACH TO ACUTE CORONARY SYNDROME PATIENTS MANAGEMENT WITH PERCUTANEOUS INTERVENTION

Российский кардиологический журнал, 2018
Aim. Clinical economical grounding of necessity for continuation of a “State Managed Program of Omsk Region “Development of Healthcare in Omsk Region” (the Program) in allowance granted supply with life saving medications of patients after endovascular ...
L. V. Shukil, О. Yu. Korennova, S. P. Podolnaya, E. P. Prikhodko   +3 more
doaj   +1 more source

Acute coronary syndrome associated with Churg-Strauss syndrome

, 2007
Annette Doris Wagner1, Gerd Peter Meyer2, Markus Rihl3, Anke Rathmann2, Ulrike Wittkop1, Henning Zeidler4, Hermann Haller1, Joachim Lotz51Department Internal Medicine, Division of Nephrology; 2Division of Cardiology; 3Division of Rheumatology ...
Anke Rathmann, Markus Rihl, et al, Ulrike Wittkop, Annette Doris Wagner, Gerd Peter Meyer   +5 more
core  

Lipid profile and non-enzymic antioxidant status in patients with acute coronary syndrome in South India.

, 2010
Aims and objectives Elevated lipid profile and reduced antioxidants accelerate the formation of atherosclerosis. Multiple lines of evidences have suggested that increased lipids and low antioxidants are the major risk factors for the incidence of acute ...
Babu S, Sarasabharati A, Victor D, Nayar P, Chockalingam M, Gururajan P, Gurumurthy P, Cherian KM, Bhuvaneshwari S   +8 more
core   +1 more source

Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention

Clinical Pharmacology &Therapeutics, EarlyView.
CYP2C19 and CYP3A4 contribute to clopidogrel bioactivation. CYP2C19 no‐function alleles diminish clopidogrel's antiplatelet effects and clinical effectiveness. Coadministration of either a CYP2C19 or a CYP3A4 inhibitor may also reduce clopidogrel's antiplatelet effects and lead to phenoconversion in patients without a CYP2C19 no‐function allele (normal/
Danwei Shao, Jean G. Malavé, Joseph S. Rossi, Francesco Franchi, Ellen C. Keeley, Dominick J. Angiolillo, George A. Stouffer, Larisa H. Cavallari, Craig R. Lee   +8 more
wiley   +1 more source

The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes:the MRC-ILA Heart Study [PDF]

, 2014
AIMS: Acute coronary syndromes (ACSs) are driven by inflammation within coronary plaque. Interleukin-1 (IL-1) has an established role in atherogenesis and the vessel-response to injury. ACS patients have raised serum markers of inflammation.
Greenwood, J.P., Hall, Alistair S., Rothman, A.M.K., Morton, Allison C., Foley, C., Chase, A., Greenwood, John P, Chase, Alex, Morton, Allison C, Wang, Duolao, Rothman, Alexander M K, Banya, Winston, Clarke, B., Gunn, J., Crossman, David C, Rothman, Alexander M. K., Crossman, David C., Flather, Marcus D, Rothman, Alexander M.K., Clarke, Bernard, Fox, Keith, Fox, K., Banya, W., Hall, Alistair S, Gunn, Julian, Flather, Marcus D., Greenwood, John P., Foley, Claire, Hall, A.S., Morton, A.C.   +29 more
core   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

The Patient with Acute Coronary Syndrome

, 2017
A growing number of patients with coronary artery diseases are subjected to surgery. Anaesthesia care providers will face patients with former or recent ACS. An ACS might also occur for the very first time during surgery or during the postoperative period.
Hennink-Schadenberg, Simon, Preckel, Benedikt   +1 more
openaire   +2 more sources

Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome

, 2017
Background: The optimal duration of dual antiplatelet therapy after percutaneous coronary intervention (PCI) remains uncertain. The objective of this study was to examine the association between duration of dual antiplatelet therapy and re ...
李啟明;高純琇;蕭斐元, Chen, Shih-Chin;Hsiao, Fei-Yuan;Lee, Chii-Ming;Hsu, William Wei-Yuan;Gau, Churn-Shiouh   +1 more
core   +1 more source